Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2025-12-25 @ 12:25 PM
NCT ID: NCT03796195
Description: Data obtained by telephone call up to 4 weeks post stellate ganglion block procedure.
Frequency Threshold: 5
Time Frame: Adverse events were monitored for 4 weeks after stellate ganglion block procedure.
Study: NCT03796195
Study Brief: (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
.5% Bupivacaine Guided right sided stelate ganglion block using .5% bupivacaine (5mLs) .5% Bupivacaine: Ultrasound guided right sided stelate ganglion block using .5% bupivacaine (5mLs) 0 None 0 1 0 1 View
Serious Events(If Any):
Other Events(If Any):